-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$2.87175.96% Upside
Lucid Diagnostics Inc. Frequently Asked Questions
-
What analysts cover Lucid Diagnostics Inc.?
Lucid Diagnostics Inc. has been rated by research analysts at Canaccord Genuity, BTIG, Needham in the past 90 days.